National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

carcinoembryonic antigen peptide 1
A nine amino acid peptide fragment of carcinoembryonic antigen (CEA), a protein that is overexpressed in several cancer cell types, including gastrointestinal, breast, and non-small cell lung. Autologous vaccination with activated autologous dendritic cells (DC) or peripheral blood mononuclear cells (PBMC) which have been exposed to CEA peptide 1 in vitro may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing CEA, thereby inhibiting tumor growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:CAP-1
Carcinoembryonic Antigen Peptide-1
Carcinoembryonic Peptide-1
CEA Peptide 1
CEA Peptide 9-mer



Previous:carbogen, carbon-11 acetate, carboplatin, carboxyamidotriazole, carboxyphenyl retinamide
Next:carcinoembryonic antigen peptide 1-6D, carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine, Cardizem, Carmubris, carmustine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov